Find Meetings & Training

May (133)

• Meeting, 4th Annual China Meeting: Collaboration and Innovation in China

  May 20, 2012 - May 23, 2012
  Shanghai, China
• EudraVigilance, Electronic Reporting of ICSRs in the EEA

  May 21, 2012 - May 23, 2012
  London, United Kingdom
• Training Course, Practical Guide for Pharmacovigilance: Clinical Trials and Post-Marketing

  May 21, 2012 - May 23, 2012
  Berlin, Germany
• Training Course, Essentials of Clinical Study Management Training Course

  May 23, 2012 - May 25, 2012
  Munich, Germany
• Meeting, 6th European Conference on Rare Diseases and Orphan Products

  May 23, 2012 - May 25, 2012
  Brussels, Belgium
• Training Course, Training Course on Benefit/Risk Management

  May 24, 2012 - May 25, 2012
  Munich, Germany
• EudraVigilance, eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD)

  May 24, 2012 - May 25, 2012
  London, United Kingdom
• Webinar, The Generic Drug User Fee Agreement - Safety, Access, and Transparency

  May 24, 2012
  Online
• Meeting, Third Cardiac Safety Workshop in Japan

  May 28, 2012 - May 29, 2012
  Tokyo, Japan
• EudraVigilance, eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD)

  May 29, 2012 - May 30, 2012
  London, United Kingdom
• EudraVigilance, EudraVigilance Information Day (12th)

  May 30, 2012
  London, United Kingdom
• Webinar, Series-The Impact of Drug Shortages on the Pharmaceutical Industry Part 3: Coordination and Communication with FDA and Worldwide Regulatory Authorities Regarding Manufacturing and Drug Shortage Issues

  May 30, 2012
  Online
• Tutorial, Full-day Workshop: Ethnicity and Multi-Regional Drug Development

  May 20, 2012
  Shanghai, China
• Tutorial, Full-day Workshop: China and Active Pharmaceutical Ingredients (APIs) – Regulations and Inspections

  May 20, 2012
  Shanghai, China
• Tutorial, Full-day Workshop: Building GCP Quality into e-Clinical Architecture: Concepts and Practices of Computer Validation

  May 20, 2012
  Shanghai, China
• Tutorial, Full-day Workshop: First in Human (FIH)

  May 20, 2012
  Shanghai, China
• Tutorial, Full-day Workshop: Drug Risk Assessment and Management at US FDA - A Case Study of Drug That Was Marketed, Withdrawn and Then Reintroduced in US Market

  May 20, 2012
  Shanghai, China
• Tutorial, Half-day Workshop: Ethical Medical Writing Practices – Every Document, Every Time, Every Country!

  May 20, 2012
  Shanghai, China
• Tutorial, Half-day Workshop: Career Development in Today's Competitive Market

  May 20, 2012
  Shanghai, China
• Webinar Archive, The Future of SPL: What’s Next? Part 2 of 4 - Opportunities and Challenges for Assessing Adverse Events and Warnings with SPL

  May 20, 2012 - May 20, 2013
  Online
• Webinar Archive, The Future of SPL: What’s Next? Part 4 of 4 - SPL Use in the Life Sciences Industry

  May 20, 2012 - May 20, 2013
  Online
• Webinar Archive, The Future of SPL: What’s Next? Part 3 of 4 - The Present and Future of SPL: Uses of SPL by the Drug Compendia

  May 20, 2012 - May 20, 2013
  Online
• Webinar Archive, The Future of SPL: What’s Next? Part 1 of 4 - The PILLBOX Initiative: Present and Future

  May 20, 2012 - May 20, 2013
  Online
• Webinar Archive, The Patient-Centered Outcomes Research Institute’s National Priorities and Research Agenda

  May 20, 2012 - May 20, 2013
  Online
• Webinar Archive, REMS and Scheduled Opioid Medications: A Review and Critique

  May 20, 2012 - May 20, 2013
  Online
• Webinar Archive, Bridging the Gap Between Images and Data Management for Clinical Trials

  May 20, 2012 - May 20, 2013
  Online
• Webinar Archive, Source Documentation, Audit Trails, and EDC: How Do They Fit Together?

  May 20, 2012 - May 20, 2013
  Online
• Webinar Archive, Biosimilar Guidances: Explanation and Discussion Part 2

  May 20, 2012 - May 20, 2013
  Online
• Webinar Archive, Biosimilar Guidances: Explanation and Discussion: Part 1

  May 20, 2012 - May 20, 2013
  Online
• Webinar Archive, CDER Town Meeting: Safety Hot Topics

  May 20, 2012 - May 20, 2013
  Online
• Webinar Archive, Meeting Global Patient Demand for Access to Medicines Prior to Approval and Launch

  May 20, 2012 - May 20, 2013
  Online
• Webinar Archive, Three-Part Series - Drug-Induced Liver Injury (DILI) Across Rx – OTC – NHP: Part 1 - Rx Session DILI: Challenges in DILI Management with Pre-Approved or Post- Approved Products

  May 20, 2012 - May 20, 2013
  Online
• Webinar Archive, Three-Part Series - Drug-Induced Liver Injury (DILI) Across Rx – OTC – NHP: Post-Approval Surveillance: DILI Risk Management Post Marketing

  May 20, 2012 - May 20, 2013
  Online
• Webinar Archive, Three-Part Series - Drug-Induced Liver Injury (DILI) Across Rx – OTC – NHP: Part 3 - NHP Session: Risks and Benefits of Natural Health Products (NHP) in DILI

  May 20, 2012 - May 20, 2013
  Online
• Webinar Archive, XEVMPD: Will Industry be Compliant on Time?

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Clinical Investigator: Module 2 - Conducting The Study

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Clinical Investigator: Module 1 - Study Preparation and Initiation

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Informed Consent

  May 20, 2012 - May 20, 2013
  Online
• Online Training Course Archive, Investigator Responsibilities: The Good, The Bad, and the Ugly

  May 20, 2012 - May 20, 2013
  Online
• Online Training Course Archive, Navigating the Regulatory Landscape—Setting Your GPS to Avoid Compliance Pitfalls

  May 20, 2012 - May 20, 2013
  Online
• Online Training Course Archive, Identifying the Best Early Phase Site for the Study ... Are You That Site?

  May 20, 2012 - May 20, 2013
  Online
• Webinar Archive, Four Part Series - Part 1: The Trial Master File—What’s In It and How Is It Managed?

  May 20, 2012 - May 20, 2013
  Online
• Webinar Archive, Four Part Series - Part 2: TMF Process Quality Improvements—A Sponsor Case Study and the DIA TMF Reference Model

  May 20, 2012 - May 20, 2013
  Online
• Webinar Archive, Trial Master File Webinar Series Part 3: Moving from a Paper to an Electronic Process for Management of TMF Content

  May 20, 2012 - May 20, 2013
  Online
• Webinar Archive, TMF Four-Part Series - Part 4: Management and Maintenance of eTMF Content

  May 20, 2012 - May 20, 2013
  Online
• Webinar Archive, CDER-CBER Town Meeting: FDA Discusses the US Module 1 Update

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Crisis Management

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Database Management

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Literature Evaluation

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Literature Searching

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Medical Inquiries

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Medical Writing

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Product Labeling

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Regulatory Issues

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Statistics for Medical Communications Professionals

  May 20, 2012 - May 20, 2013
  Online
• Webinar Archive, Medical Information Responses: What’s Everyone Saying?

  May 20, 2012 - May 20, 2013
  Online
• Webinar Archive, Series: The Impact of Drug Shortages on the Pharmaceutical Industry Part 1: FDA Discusses Drug Shortages: Causes, Trends, Impact and Prevention

  May 20, 2012 - May 20, 2013
  Online
• Webinar Archive, How to Lead and Deliver Value as a Medical Science Liaison: The $64,000 Question

  May 20, 2012 - May 20, 2013
  Online
• eLearning, A Tour of FDA

  May 20, 2012 - May 20, 2013
  Online
• eLearning, A Tour of Health Canada

  May 20, 2012 - May 20, 2013
  Online
• eLearning, A Tour of Health Europe

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Aspects of Regulatory History

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Bioresearch Monitoring Program (BIMO): Introduction

  May 20, 2012 - May 20, 2013
  Online
• eLearning, The Clinical Development Process: Investigational Product, Plan, and Data Management

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Drug Safety & Adverse Event Reporting

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Ethical Review Boards

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Ethics as the Foundation to Clinical Research

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Awareness of FDA Inspections for Pharmaceutical Manufacturers

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Biotechnology: An Overview of Compliance Considerations

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Change Control

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Clinical Trial Audits and Consequences of Non-Compliance

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Computerized Systems Inspections in the Medical Device Industry

  May 20, 2012 - May 20, 2013
  Online
• eLearning, European Union Clinical Trials Directive

  May 20, 2012 - May 20, 2013
  Online
• eLearning, GMP Principals of SOPs

  May 20, 2012 - May 20, 2013
  Online
• eLearning, GMP Updates - Enforcement Changes at the New FDA

  May 20, 2012 - May 20, 2013
  Online
• eLearning, GMPs for API Bulk Manufacturers

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Good Clinical Practices (GCPs) for New Product Investigations

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Good Laboratory Practices (GLPs)

  May 20, 2012 - May 20, 2013
  Online
• eLearning, GxPs

  May 20, 2012 - May 20, 2013
  Online
• eLearning, HIPAA - The Impact on Clinical Research

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Introduction to GMPs

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Investigational Product Development

  May 20, 2012 - May 20, 2013
  Online
• eLearning, ISO 14155: Obligations of Sponsors and Monitors for Medical Device Trials

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Key Concepts of Process Validation

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Laboratory Specimens for Clinical Research

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Medical Device Safety Reporting

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Orientation to GMP Compliance

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Overview of the Clinical Research Process

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Part 11: Electronic Records and Signatures - Application

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Part 11: Electronic Records and Signatures - Application

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Principles of Good Documentation

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Protection of Human Subjects in Clinical Trials

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Selecting and Managing Clinical Contract Research Organizations (CROs)

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Understanding Post-Approval Changes

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Computerized Systems Inspections in the Pharmaceutical Industry

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Basics of the PhRMA Code

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Basics of AdvaMed Code

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Eucomed Guidelines on Interactions with Healthcare Professionals

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Introduction to Medical Devices

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Foreign Corrupt Practices Act

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Global Anti-bribery

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Variations to Marketing Authorisation in Europe

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Registration of Monoclonal Antibodies

  May 20, 2012 - May 20, 2013
  Online
• eLearning, The ANDA: Requirements for Obtaining FDA Approval for a Generic Product in the USA

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Pharmacokinetics and Pharmacodynamics in Drug Registration

  May 20, 2012 - May 20, 2013
  Online
• Webinar Archive, Two-part Series: What You Need to Know about FDA’s Drug Listing and Import Process-Part 2 Importation Perspective

  May 20, 2012 - May 20, 2013
  Online
• Webinar Archive, Pharmaceuticals and Companion Diagnostics: Regulation and Reimbursement

  May 20, 2012 - May 20, 2013
  Online
• Webinar Archive, Using Patient-reported Outcomes to Assess Comparative Safety and Tolerability: Methodological and Regulatory Considerations

  May 20, 2012 - May 20, 2013
  Online
• Webinar Archive, Medical Science Liaison Metrics: From Evolution to Commencement

  May 20, 2012 - May 20, 2013
  Online
• Webinar Archive, Series: The Impact of Drug Shortages on the Pharmaceutical Industry Part 2: Drug Shortages within the Pharmaceutical Supply Chain: Impact on Patient Safety and Gray Market Control

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Introduction to the European Union Institutions and Regulatory Authority

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Introduction to US Institutions and Regulatory Authority (FDA)

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Introduction to Japanese Institutions and Regulatory Authorities

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Overview of the CTD and the eCTD

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Introduction to the International Conference on Harmonization (ICH)

  May 20, 2012 - May 20, 2013
  Online
• eLearning, The Regulatory Development Cycle of a Drug

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Basics of Pharmacovigilance

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Basics of Clinical Trials

  May 20, 2012 - May 20, 2013
  Online
• eLearning, How to Register Medicinal Products through the Centralized Procedure

  May 20, 2012 - May 20, 2013
  Online
• eLearning, How to Register Medicinal Products through the Mutual Recognition Procedure

  May 20, 2012 - May 20, 2013
  Online
• eLearning, How to Maintain Marketing Approvals in Europe for Centrally Authorized Products

  May 20, 2012 - May 20, 2013
  Online
• eLearning, How to Register a New Drug in the USA

  May 20, 2012 - May 20, 2013
  Online
• eLearning, How to Register Medicinal Products through the Decentralized Procedure

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Access to Unapproved Drugs through Compassionate Use

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Regulatory Requirements for the Conduct of Clinical Trials in Europe

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Orphan Drugs in the USA, European Union, and Japan

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Regulatory Requirements for the Submission of Investigational New Drug Applications in the USA (INDs)

  May 20, 2012 - May 20, 2013
  Online
• eLearning, Meeting Opportunities with Regulatory Agencies

  May 20, 2012 - May 20, 2013
  Online
• Webinar Archive, 510(k) Device Modifications – Deciding When to Submit a 510(k) for a Change to an Existing Device

  May 20, 2012 - May 20, 2013
  Online
• Webinar Archive, Two-part Series: What You Need to Know about FDA’s Drug Listing and Import Process: Part 1- Drug Listing/Regulatory Perspective

  May 20, 2012 - May 20, 2013
  Online
• Webinar Archive, The “Nuts and Bolts” of Preparing a New Drug Application (NDA): Industry and FDA Perspectives

  May 20, 2012 - May 20, 2013
  Online
• Webinar Archive, CDER Data Standards Common Issues Document

  May 20, 2012 - May 20, 2013
  Online
• Webinar Archive, Steps to Preparing for a Successful FDA Advisory Committee Meeting

  May 20, 2012 - May 20, 2013
  Online

June (39)

• EudraVigilance, EudraVigilance - Electronic Reporting of ICSRs in the EEA

  Jun 04, 2012 - Jun 06, 2012
  Prague – Vinohrady, Czech Republic
• Online Training Course, Interactions with the FDA During the IND/NDA Phases

  Jun 04, 2012 - Jun 05, 2012
  Online
• Webinar, Series: The Impact of Drug Shortages on the Pharmaceutical Industry Part 4: Potential Policy Solutions to Solve Drug Shortage Problem

  Jun 06, 2012
  Online
• EudraVigilance, eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD)

  Jun 07, 2012 - Jun 08, 2012
  Prague – Vinohrady, Czech Republic
• Online Training Course, Regulatory Aspects of Prescription Drug/Biologics Advertising and Promotional Labeling

  Jun 07, 2012
  Online
• Training Course, IPR Workshop - Patenting Pharmaceuticals in India: Practical Approaches to a Vibrant Market

  Jun 08, 2012
  New Delhi, India
• Meeting, 1st CMC Forum in Japan: Challenges for Quality Improvement in Asia

  Jun 11, 2012
  Tokyo, Japan
• EudraVigilance, eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD)

  Jun 11, 2012 - Jun 12, 2012
  Athens, Greece
• Webinar, Opioid Class REMS: Is it finally here?

  Jun 11, 2012
  Online
• Online Training Course, Regulatory Considerations for Clinical Development Programs

  Jun 11, 2012 - Jun 13, 2012
  Online
• Meeting, Adapting to the new EU pharmacovigilance legislation – A joint DIA / EFGCP Workshop

  Jun 12, 2012 - Jun 13, 2012
  London, United Kingdom
• Training Course, 5th DIA Regulatory Affairs Training Course in Japan

  Jun 13, 2012 - Mar 13, 2013
  Tokyo, Japan
• EudraVigilance, EudraVigilance - Electronic Reporting of ICSRs in the EEA

  Jun 13, 2012 - Jun 15, 2012
  Athens, Greece
• Training Course, 1st FDA IND/NDA Training Course in Japan

  Jun 14, 2012 - Jun 15, 2012
  Kanagawa, Japan
• Webinar, Current Initiatives in the Area of Active Pharmaceutical Ingredients (API)

  Jun 14, 2012
  Online
• Training Course, European Regulatory Affairs

  Jun 14, 2012 - Jun 15, 2012
  Berlin, Germany
• EudraVigilance, eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD)

  Jun 18, 2012 - Jun 19, 2012
  San Marino, San Marino
• EudraVigilance, EudraVigilance - Electronic Reporting of ICSRs in the EEA

  Jun 20, 2012 - Jun 22, 2012
  San Marino, San Marino
• Training Course, Risk Management and Safety Communications Strategies

  Jun 23, 2012 - Jun 24, 2012
  Philadelphia, PA, United States
• Annual Meeting, DIA 2012 48th Annual Meeting: Collaborate to Innovate

  Jun 24, 2012 - Jun 28, 2012
  Philadelphia, PA, United States
• Training Course, #47: Overview of Drug Development

  Jun 24, 2012
  Philadelphia, PA, United States
• Meeting, Trusted Identities For Cloud Collaboration: A One-day Conference on How Standards Accelerate Collaboration in the Cloud

  Jun 24, 2012
  Philadelphia, PA, United States
• Training Course, #48: The Art of Writing a Clinical Overview

  Jun 24, 2012
  Philadelphia, PA, United States
• Training Course, #46: Fundamentals of Project Management for Non-Project Managers

  Jun 24, 2012
  Philadelphia, PA, United States
• Training Course, #45: Preparing for a US FDA Advisory Committee Meeting

  Jun 24, 2012
  Philadelphia, PA, United States
• Tutorial, #20: Japan Regulatory Environment: Overview of the Organization, Processes, Systems, and Changes Affecting Pharmaceutical Development

  Jun 24, 2012
  Philadelphia, PA, United States
• Tutorial, #21: FDA Enforcement: Understanding the Agency's Authority, How Violations Occur, How to Prevent Them, and How to Respond If Violations Do Occur

  Jun 24, 2012
  Philadelphia, PA, United States
• Tutorial, #22: Utilizing Chemistry, Manufacturing, and Controls in Drug Development

  Jun 24, 2012
  Philadelphia, PA, United States
• Tutorial, #23: Global Market Access: Essential Knowledge for Clinical Trial Design

  Jun 24, 2012
  Philadelphia, PA, United States
• Tutorial, #24: A Device Primer: 510(k)s, PMAs, IDEs

  Jun 24, 2012
  Philadelphia, PA, United States
• Tutorial, #40: Understanding and Navigating the Regulatory System in China

  Jun 24, 2012
  Philadelphia, PA, United States
• Tutorial, #43: Clinical Statistics for Nonstatisticians

  Jun 24, 2012
  Philadelphia, PA, United States
• Tutorial, #41: Quality Oversight of CROs - Clinical Vendors

  Jun 24, 2012
  Philadelphia, PA, United States
• Tutorial, #42: Regulatory Affairs for Biologics

  Jun 24, 2012
  Philadelphia, PA, United States
• Tutorial, #30: Regulatory Affairs in the European Union: An Overview of Registration Procedures for Medicinal Products in the EU

  Jun 24, 2012
  Philadelphia, PA, United States
• Tutorial, #31: Leadership: How to Organize and Lead People in Group Work

  Jun 24, 2012
  Philadelphia, PA, United States
• Tutorial, #32: Designing, Operating and Evaluating Patient Registries

  Jun 24, 2012
  Philadelphia, PA, United States
• Tutorial, #34: Fourteen Steps from Research to Development

  Jun 24, 2012
  Philadelphia, PA, United States
• Tutorial, #33: Understanding Comparative Effectiveness Research (CER) in the Biopharmaceutical Industry

  Jun 24, 2012
  Philadelphia, PA, United States

July (4)

• Online Training Course, Adverse Event Reporting Requirements: IND and Post-Marketing

  Jul 09, 2012 - Jul 11, 2012
  Online
• Online Training Course, Executing and Controlling Biopharmaceutical Projects

  Jul 10, 2012 - Jul 26, 2012
  Online
• Online Training Course, Advanced Clinical Statistics for Nonstatisticians

  Jul 16, 2012 - Jul 24, 2012
  Online
• Online Training Course, Supplements and Other Changes to an Approved Application

  Jul 30, 2012
  Online

August (5)

• Online Training Course, Introduction to Portfolio Management and Performance Metrics

  Aug 02, 2012 - Aug 16, 2012
  Online
• Training Course, New Drug Product Development and Lifecycle Management

  Aug 06, 2012 - Aug 07, 2012
  Horsham, PA, United States
• Training Course, Clinical Project Management

  Aug 08, 2012 - Aug 10, 2012
  Horsham, PA, United States
• Training Course, Pragmatic Approaches to Drug Safety Across the Premarketing and Postmarketing Continuum

  Aug 13, 2012 - Aug 15, 2012
  Horsham, PA, United States
• Training Course, Regulatory Affairs Part I & II: The IND and NDA Phases

  Aug 13, 2012 - Aug 16, 2012
  Boston, MA, United States